The 2023 guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease, considering social determinants of health and incorporating the principles of shared decision-making and team-based care. In this interview, Kristin Newby, MD, FACC, and Nanette Kass Wenger MD, MACC, discuss Behind the ACC 2023 Guideline for Chronic CAD: Conversations and Controversies.

Related References:

1. Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., Kazi, D. S., Kolte, D., Kumbhani, D. J., LoFaso, J., Mahtta, D., Mark, D. B., Minissian, M., Návar, A. M., Patel, A. R., . . . Williams, M. S. (2023). 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease. Journal of the American College of Cardiology, 82(9), 833–955. https://doi.org/10.1016/j.jacc.2023.04.003.